Ascendiant Capital Markets Forecasts SINT Q1 Earnings

Sintx Technologies, Inc. (NASDAQ:SINT) – Equities research analysts at Ascendiant Capital Markets issued their Q1 2027 earnings per share estimates for Sintx Technologies in a report released on Tuesday, April 7th. Ascendiant Capital Markets analyst E. Woo expects that the company will post earnings of ($0.48) per share for the quarter. Ascendiant Capital Markets has a “Buy” rating and a $12.00 price objective on the stock. Ascendiant Capital Markets also issued estimates for Sintx Technologies’ Q2 2027 earnings at ($0.49) EPS, Q3 2027 earnings at ($0.47) EPS, Q4 2027 earnings at ($0.45) EPS and FY2027 earnings at ($1.90) EPS.

Several other equities analysts also recently commented on the company. HC Wainwright initiated coverage on Sintx Technologies in a research report on Monday. They set a “buy” rating and a $10.00 target price for the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Sintx Technologies in a research note on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $11.00.

Sintx Technologies Trading Down 2.4%

Shares of SINT opened at $2.80 on Tuesday. Sintx Technologies has a 1 year low of $1.71 and a 1 year high of $6.78. The stock has a 50 day simple moving average of $2.77 and a 200-day simple moving average of $3.35. The stock has a market cap of $11.54 million, a PE ratio of -0.49 and a beta of 0.66.

Institutional Trading of Sintx Technologies

Several hedge funds have recently modified their holdings of SINT. Geode Capital Management LLC raised its stake in shares of Sintx Technologies by 53.4% in the fourth quarter. Geode Capital Management LLC now owns 26,624 shares of the company’s stock valued at $103,000 after acquiring an additional 9,265 shares during the last quarter. Virtus Wealth Solutions LLC bought a new stake in Sintx Technologies during the 3rd quarter worth approximately $388,000. Finally, Veracity Capital LLC increased its holdings in Sintx Technologies by 10.3% during the 3rd quarter. Veracity Capital LLC now owns 79,928 shares of the company’s stock valued at $327,000 after purchasing an additional 7,464 shares in the last quarter. Institutional investors and hedge funds own 18.38% of the company’s stock.

Sintx Technologies Company Profile

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.